Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma

References

• Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351:1860–1873.
   PubMed Web of Science ®Google Scholar
• Kuehl WM, Bergsagel PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer. 2002;2:175–187.
   PubMed Web of Science ®Google Scholar
• Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol. 2005;23:6333–6338.
   PubMed Web of Science ®Google Scholar
• Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002;66:407–425.
   PubMed Web of Science ®Google Scholar
• Day JP, Marder BA, Morgan WF. Telomeres and their possible role in chromosome stabilization. Environ Mol Mutagen. 1993;22:245–249.
   PubMed Web of Science ®Google Scholar
• Brennan SK, Wang Q, Tressler R, et al. Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms. PloS One. 2010;5:e12487.
   PubMed Web of Science ®Google Scholar
• Ropio J, Merlio JP, Soares P, et al. Telomerase activation in hematological malignancies. Genes (Basel). 2016;7:E61.
   PubMed Web of Science ®Google Scholar
• Panero J, Santos PD, Slavutsky I. Telomere protein complexes and their role in lymphoid malignancies. Front Biosci. 2017;9:17–30.
   Google Scholar
• de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005;19:2100–2110.
   PubMed Web of Science ®Google Scholar
• Broccoli D, Smogorzewska A, Chong L, et al. Human telomeres contain two distinct Myb-related proteins, TERF1 and TERF2. Nat Genet. 1997;17:231–235.
   PubMed Web of Science ®Google Scholar
• Pal D, Sharma U, Singh SK, et al. Over-expression of telomere binding factors (TERF1 & TERF2) in renal cell carcinoma and their inhibition by using induce apoptosis, reduce cell proliferation and migration in vitro SiRNA. PLoS One 2015;10:e0115651.
   PubMed Web of Science ®Google Scholar
• Matsutani N, Yokozaki H, Tahara E, et al. Expression of telomeric repeat binding factor 1 and 2 and TERF1-interacting nuclear protein 2 in human gastric carcinomas. Int J Oncol. 2001;19:507–512.
   PubMed Web of Science ®Google Scholar
• Butler KS, Hines WC, Heaphy CM, et al. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas. Cancer Med. 2012;1:165–175.
   PubMed Web of Science ®Google Scholar
• Ye JZ, Donigian JR, Van Overbeek M, et al. TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J Biol Chem. 2004;279:47264–47271.
   PubMed Web of Science ®Google Scholar
• Oh BK, Kim YJ, Park C, et al. Up-regulation of telomere-binding proteins, TERF1, TERF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Am J Pathol. 2005;166:73–80.
   PubMed Web of Science ®Google Scholar
• Bellon M, Datta A, Brown M, et al. Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T‐cell leukemia. Int J Cancer. 2006;119:2090–2097.
   PubMed Web of Science ®Google Scholar
• Zhong FL, Batista LF, Freund A, et al. TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends. Cell. 2012;150:481–494.
   PubMed Web of Science ®Google Scholar
• Panero J, Stanganelli C, Arbelbide J, et al. Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression. Blood Cells Mol Dis. 2014;52:134–139.
   PubMed Web of Science ®Google Scholar
• Sfeir A, Kabir S, van Overbeek M, et al. Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science. 2010;327:1657–1661.
   PubMed Web of Science ®Google Scholar
• Bae NS, Baumann P. A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol Cell. 2007;26:323–334.
   PubMed Web of Science ®Google Scholar
• Li X, Liu W, Wang H, et al. Rap1 is indispensable for TRF2 function in etoposide-induced DNA damage response in gastric cancer cell line. Oncogenesis. 2015;4:e144.
   PubMed Web of Science ®Google Scholar
• Panero J, Arbelbide J, Fantl DB, et al. Altered mRNA expression of telomere-associated genes in monoclonal gammopathy of undetermined significance and multiple myeloma. Mol Med. 2010;16:471.
   PubMed Web of Science ®Google Scholar
• Gay-Bellile M, Romero P, Cayre A, et al. ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis. J Path: Clin Res. 2016;2:234–246.
   PubMedGoogle Scholar
• Qian D, Cheng J, Ding X, et al. PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis. Onco Targets Ther. 2016;9:4821–4831.
   PubMed Web of Science ®Google Scholar
• Shi R, Zhao Z, Zhou H, et al. Reduced expression of PinX1 correlates to progressive features in patients with prostate cancer. Cancer Cell Int. 2014;14:46.
   PubMed Web of Science ®Google Scholar
• Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol. 2005;23:3412–3420.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Morgan GJ, Walker BA, Davies FE. The genetic architecture of multiple myeloma. Nat Rev Cancer. 2012;12:335–348.
   PubMed Web of Science ®Google Scholar
• Hemann MT, Strong MA, Hao LY, et al. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 2001;107:67–77.
   PubMed Web of Science ®Google Scholar
• Shiratsuchi M, Muta K, Abe Y, et al. Clinical significance of telomerase activity in multiple myeloma. Cancer. 2002;94:2232–2238.
   PubMed Web of Science ®Google Scholar
• Wu KD, Orme LM, Shaughnessy J, et al. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood. 2003;101:4982–4989.
   PubMed Web of Science ®Google Scholar
• Hu H, Zhang Y, Zou M, et al. Expression of TERF1, TERF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer. J Cancer Res Clin Oncol. 2010;136:1407–1414.
   PubMed Web of Science ®Google Scholar
• Chen XH, Tong Y, Xu WL, et al. Expression of telomere binding factor 2 (TERF2) on leukemia cell lines and primary leukemia cells. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2008;37:170–175.
   PubMedGoogle Scholar
• Poncet D, Belleville A, de Roodenbeke CT, et al. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia. Blood. 2008;111:2388–2391.
   PubMed Web of Science ®Google Scholar
• Shi JM, Huang H, Chen QF, et al. A study of the relationship between expression level of TRF1 protein and telomerase activity in human acute leukemia. J Zhejiang Univ Sci B. 2006 Feb 8;7:154–158.
   PubMedGoogle Scholar
• Hoxha M, Fabris S, Agnelli L, et al. Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia. Genes Chromosomes Cancer. 2014;53:612–621.
   PubMed Web of Science ®Google Scholar
• Gelmini S, Poggesi M, Distante V, et al. Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. Cancer Lett. 2004;216:81–87.
   PubMed Web of Science ®Google Scholar
• Campbell LJ, Fidler C, Eagleton H, et al. hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia. Leukemia. 2006;20:671.
   PubMed Web of Science ®Google Scholar
• Shi M, Cao M, Song J, et al. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway. Mol Cancer. 2015;14:66.
   PubMed Web of Science ®Google Scholar